Europe Hemostasis Diagnostics Market: Market Estimation, Dynamics, Country Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023

Market Outline: Europe Hemostasis Diagnostics Market
Hemostasis diagnostics are the devices used to determine the hemostatic defects, which cause excessive bleeding. Hemostasis is defined as the stopping or slowing the blood flow from damaged blood vessel. During the hemostasis, blood changes from liquid state to the gelatinous state. Hemostasis maintained in the body by three mechanisms namely, blood coagulation, platelet plug formation, and vasoconstriction. Hemostasis diagnostics may help to predict the cause of bleeding during surgery by identifying the hemostatic defects in patients. Different types of tests such as prothrombin test, activated clotting time, platelet function, and other coagulation tests are carried to identify the hemostasis defects.

Market Dynamics: Europe Hemostasis Diagnostics Market
Increase in the prevalence of hemostasis related disease in Europe countries (according to The European National Registry of Congenital Coagulopathies 2017, the number of cases identified with hemostasis is increased from 7000 in 2000 to 11,000 in 2015), rise in number of surgery cases, rise in R&D investment for novel tests and devices innovation, and well developed healthcare infrastructure are expected to boost the hemostasis diagnostics market. However, high cost of advanced hemostasis products, and stringent regulations for the test approvals are expected to hamper the growth of hemostasis diagnostics market.

A sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/europe-hemostasis-diagnostics-market/#ulp-4H8Z4LpNMLEuOnnx

Market Scope: Europe Hemostasis Diagnostics Market
Hemostasis diagnostics market is segmented on the basis of product type, test type, technology, and end user
Based on the product type, the market is segmented into the following:
• Systems
• Consumables
• Point-of-Care Testing Devices
Based on the test type, the market is segmented into the following:
• Fibrinogen Test
• Activated Clotting Time
• Platelet Function
• Prothrombin Time
• Heparin & Protamine Dose-Response Test For ACT
• Activated Partial Thromboplastin Time
• Anti-Factor Xa
• Other Coagulation Tests
Based on the technology, the market is segmented into the following:
• Optical
• Mechanical
• Electrochemical
• Others
Based on the end user, the market is segmented into the following:
• Hospitals
• Clinics
• Diagnostic Centres
• Others (POC)

To view TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/europe-hemostasis-diagnostics-market/#ulp-c654SbFYO64MsOhu


Regional Analysis: Europe Hemostasis Diagnostics Market
Geographically, Europe hemostasis diagnosis market is segmented into U.K., France, Germany, Russia, Spain, Italy, Poland, and Rest of Europe. U.K. hemostasis diagnostics market accounted for significant share, which is attributed to rise in prevalence of hemophilia (according to World Federation of Hemophilia Global Survey 2010, approximately 6,573 people are suffering from hemophilia), increase in prevalence of cardiovascular diseases, and adoption of newer technologies are expected to propel the market in U.K. France hemostasis diagnostics market is growing due to rise in funding for launching test kits. For instance, in March 2016, Emosis, a French company raised 1 Mn Euros funding from Cap Innov’Est for the development of hemostasis test kits. Germany hemostasis market growth driven by increase in the R&D for innovation of newer products, rise in prevalence of hemophilia disease, and expansion of business by market players in the country. Russia hemostasis diagnostics market is rising due to organization of training programs for doctors on coagulation testing by market players.

Competition Assessment: Europe Hemostasis Diagnostics Market
Some of the players in the Europe hemostasis diagnostics market include:
• Hoffmann-La Roche Ltd. (Switzerland)
• Sysmex Corporation (Japan)
• Abbott Laboratories (U.S.)
• Alere Inc. (U.S.)
• Nihon Kohden Corporation (Japan)
• Siemens Healthineers (Germany)
• Danaher Corporation (U.S.)
• Instrumentation Laboratory (U.S.)
• Grifols S.A (Spain)
• Beckman Coulter, Inc. (U.S.)
• Emosis Diagnostics (France)

Need more information about this report @
https://www.precisionbusinessinsights.com/market-reports/europe-hemostasis-diagnostics-market/#ulp-14mlyhjMGhVjZqa3

Key Features of the Report:
• The report provides granular level information about the market size, regional market share, and forecast from 2017-2023
• The report covers in-detail insights about the competitor’s overview, key findings, and their key strategies
• The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
• The report tracks recent innovations, key developments and start-up’s details that are working in the industry
• The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/europe-hemostasis-diagnostics-market/

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com

This release was published on openPR.